San Francisco, 4 March 2019: The Report EuropeIn Vitro Diagnostics (IVD) Market Analysis By Product (Instruments, Reagents,
Services), By Technique (Immunology, Hematology, Clinical Chemistry,
Coagulation, Microbiology, Molecular Diagnostics) By Application (Infectious
Diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune
Diseases, STD, Drug Testing) by End-use (Hospitals, Laboratory, Home Care,
Point-Of-Care Testing), And Segment Forecasts To 2024
The Europe IVD market is expected to reach over USD 15.5 billion by 2024
according to a new report by Grand View Research, Inc. This expected increase
in the demand is ascribed to the presence of novel and promising technologies
in clinical laboratories, such as the introduction of Troponin T test by Roche
Diagnostics in May, 2011.
Persistent research and development efforts
made to introduce automation in laboratories that perform analytical testsare
projected to propel the market growth over the forecast period. Clinical
laboratory operations require automated analyzers to cope with the large test
volumes,which enhance the overall operational workflow. It minimizes the need
for dedicated operator training andnegates the risk of human errors. In
addition, the rising demand for portable and handheld IVD devicesis one of the
major factors pushing forward the growth of the market.
The increasing prevalence of chronic
diseases, such as diabetes, cancers, and cardiac dysfunctions and the rising
geriatric population coupled with the rising awareness towards early diagnosis
in low-income countries, such as Bulgaria, Finland, Malta, and Estoniaare the
potential drivers of the Europe IVD market.
Access Research Report of Europe IVD
Market@ www.grandviewresearch.com/industry-analysis/europe-in-vitro-diagnostics-ivd-market
Further key findings from the study suggest:
· In 2015, the reagents segment dominated the
Europe IVD market due to its increasing number of applications in the companion
diagnostics area and the introduction of disease specific kits, such as the
XpertTB kit
· The IVD instruments market is anticipated
to show lucrative growth due to the introduction of portable instruments, such
as MinION Analyzer by Oxford Nanopore, and the availability of various
platforms to performtarget sequence analysis, thereby driving the overall
demand
· Germany is one of the largest segments in
2015 with a share of over 19% owing to the presence of a larger geriatric
population base in this region and the amendment ofthe German lawfor the
prevention of hospital-acquired infections
· UK is expected to be the fastest growing
regionduring the forecast period.The rising demand for the point-of-care
devices coupled with the government interventions to incorporate innovative,
cost-effective solutions in the healthcare services are expected to drive the
market growth during the forecast period.
· The hospital-based IVD testing segment held
the largest share of over 45% in 2015. The highprocedure volumes in this
segment, is one of the major reasons resulting inthehigh share and;hence, is
anticipated to maintain its market position over the forecast period.
· The market players of the Europe IVD market
include Alere, Inc., bioMerieux, Inc., Hologic, Inc. (Gen-Probe), Roche
Diagnostics, Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation,
Abbott Laboratories, Inc., Becton, Dickinson (BD) and Company, Inc., and
Siemens Healthcare GmbH
· The presence of major IVD market players in
Europe accelerates the penetration of the IVD products throughout the European
Union. For instance, in September 2014, Roche Diagnostics launched the CE
approved Cobas 6800/8800 systems, which offers IVD-based viral load monitoring
withenhanced flexibility and automation.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the
Europe IVD market on the basis of product, technology, application, test
location, and region:
Europe In-Vitro Diagnostics (IVD) Market,
by Product (USD Million), 2013 - 2024
·
IVD Instruments
·
IVD Reagents
·
Services
·
Data Management
Europe In-Vitro Diagnostics (IVD) Market,
by Technique (USD Million), 2013 - 2024
·
Immunochemistry
·
Microbiology
·
Molecular diagnostics
·
Hematology
·
Clinical Chemistry
·
Coagulation
·
Other Clinical Instruments
Europe In-Vitro Diagnostics (IVD) Market,
by Application (USD Million), 2013 - 2024
·
Infectious Diseases
·
Diabetes
·
Oncology/Cancer
·
Cardiology
·
Nephrology
·
Autoimmune Diseases
·
Drug Testing
·
Others
Europe In-Vitro Diagnostics (IVD) Market,
by End-use (USD Million), 2013 - 2024
·
Hospitals
·
Laboratory
·
Patient self-testing
·
Point-of-care testing
·
Academics
·
Others
Europe In-Vitro Diagnostics (IVD) Market,
by Country (USD Million), 2013 - 2024
·
Germany
·
UK
·
France
·
Switzerland
·
Spain
·
Italy
·
Belgium
·
Austria
·
Netherlands
·
Sweden
Access Press Release of
Europe IVD Market@ www.grandviewresearch.com/press-release/europe-in-vitro-diagnostics-ivd-market-analysis
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
